Ichor Therapeutics Company

The services they offer to universities and other biotech firms include stem cell research, research on senolytics (drugs to combat senescent cells), and lifespan studies. Ichor also has a portfolio of subsidiary companies, most of which are focused on a specific area of longevity and regenerative-related research.
Technology:
Geroscience
Industry:
Service
Headquarters:
La Fayette, New York, United States
Founded Date:
2013
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
1
Total Funding:
4496000
Estimated Revenue:
Less than $1M
Last Funding Date:
2018
Last Funding Type:
Seed
Register and Claim Ownership